Early wide systolic pressure excursion is associated with clinical outcomes in acute branch atheromatous disease

早期收缩压大幅波动与急性分支动脉粥样硬化性疾病的临床结局相关。

阅读:1

Abstract

OBJECTIVES: Acute branch atheromatous disease (BAD) is frequently associated with early neurological deterioration (END), which is a significant predictor of poor clinical outcomes. The present study aimed to investigate the relationship between early substantial fluctuations in blood pressure (BP) and both 72-h END and 3-month clinical outcomes in patients diagnosed with acute BAD. METHODS: This investigation included a cohort of 241 patients (mean age 66.10 ± 11.31 years) diagnosed with acute BAD, all of whom underwent comprehensive clinical assessment and continuous blood pressure monitoring. Both maximum and minimum BP levels were systematically recorded during the 72 h following the onset of neurological symptoms. END was defined as an increase of 2 or more points in the National Institutes of Health Stroke Scale (NIHSS) score within 72 h after the onset of stroke. RESULTS: The results revealed that 23.65% (57/241) of the patients experienced END, while 78.42% (189/241) had favorable clinical outcomes. The patients who experienced END exhibited significantly wider systolic pressure (SP) excursions compared to those without END (p = 0.031). In fully adjusted models, after adjusting for potential confounders, no significant association was observed between wide SP excursions and END (p = 0.535). Wide SP excursions were associated with a poor prognosis at 3 months in the adjusted models (p < 0.05). CONCLUSION: Wider SP excursions were independently associated with an elevated risk of poor clinical outcomes in patients with BAD. These findings suggest that excessive fluctuations in early systolic pressure should be controlled during the first 72 h following symptom onset in individuals with acute BAD.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。